{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:19Z","timestamp":1792784179466,"version":"4.5.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972643"],"award-info":[{"award-number":["81972643"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Project","award":["2021YJ0201"],"award-info":[{"award-number":["2021YJ0201"]}]},{"name":"Luxian People's Government and Southwest Medical University Scientific and Technological Achievements Transfer and Transformation Strategic Cooperation Project","award":["2019LXXNYKD-07"],"award-info":[{"award-number":["2019LXXNYKD-07"]}],"id":[{"id":"https:\/\/ror.org\/00g2rqs52","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12072-022-10351-6","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T05:02:46Z","timestamp":1654059766000},"page":"741-754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Liqiong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueshui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"10351_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","volume":"4","author":"PA Revill","year":"2019","unstructured":"Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, et al. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol. 2019;4:545\u2013558","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10351_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(Suppl 1):4\u201313","journal-title":"Hepatology"},{"key":"10351_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"10351_CR4","doi-asserted-by":"publisher","first-page":"1073509","DOI":"10.1155\/2018\/1073509","volume":"2018","author":"H Kim","year":"2018","unstructured":"Kim H, Jang E, Kim SY, Choi JY, Lee NR, Kim DS, et al. Preclinical evaluation of in vitro and in vivo antiviral activities of KCT-01, a new herbal formula against hepatitis B virus. Evid Based Complement Alternat Med. 2018;2018:1073509","journal-title":"Evid Based Complement Alternat Med"},{"key":"10351_CR5","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1053\/j.gastro.2020.11.057","volume":"160","author":"JM Paik","year":"2021","unstructured":"Paik JM, Younossi Y, Henry L, Mishra A, Younossi ZM. Recent trends in the global burden of hepatitis B virus: 2007\u20132017. Gastroenterology. 2021;160:1845\u20136.e3","journal-title":"Gastroenterology"},{"key":"10351_CR6","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","volume":"388","author":"JD Stanaway","year":"2016","unstructured":"Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016;388:1081\u20131088","journal-title":"Lancet"},{"key":"10351_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1006\/viro.1994.1647","volume":"205","author":"F Sugata","year":"1994","unstructured":"Sugata F, Chen HS, Kaneko S, Purcell RH, Miller RH. Analysis of the X gene promoter of woodchuck hepatitis virus. Virology. 1994;205:314\u2013320","journal-title":"Virology"},{"key":"10351_CR8","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1128\/JVI.78.23.12725-12734.2004","volume":"78","author":"MJ Bouchard","year":"2004","unstructured":"Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. J Virol. 2004;78:12725\u201312734","journal-title":"J Virol"},{"key":"10351_CR9","doi-asserted-by":"publisher","first-page":"33039","DOI":"10.1038\/srep33039","volume":"6","author":"Y Qian","year":"2016","unstructured":"Qian Y, Wang B, Ma A, Zhang L, Xu G, Ding Q, et al. USP16 downregulation by carboxyl-terminal truncated HBx promotes the growth of hepatocellular carcinoma cells. Sci Rep. 2016;6:33039","journal-title":"Sci Rep"},{"key":"10351_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2018.12.003","volume":"444","author":"X Mao","year":"2019","unstructured":"Mao X, Tey SK, Ko FCF, Kwong EML, Gao Y, Ng IO, et al. C-terminal truncated HBx protein activates caveolin-1\/LRP6\/\u03b2-catenin\/FRMD5 axis in promoting hepatocarcinogenesis. Cancer Lett. 2019;444:60\u201369","journal-title":"Cancer Lett"},{"key":"10351_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4149\/av_2013_04_389","volume":"57","author":"M Motavaf","year":"2013","unstructured":"Motavaf M, Safari S, Saffari Jourshari M, Alavian SM. Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein. Acta Virol. 2013;57:389\u2013396","journal-title":"Acta Virol"},{"key":"10351_CR12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s00535-011-0415-9","volume":"46","author":"SA Ng","year":"2011","unstructured":"Ng SA, Lee C. Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol. 2011;46:974\u2013990","journal-title":"J Gastroenterol"},{"key":"10351_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrg.2017.80","volume":"19","author":"F Lyko","year":"2018","unstructured":"Lyko F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat Rev Genet. 2018;19:81\u201392","journal-title":"Nat Rev Genet"},{"key":"10351_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrg.2017.33","volume":"18","author":"X Wu","year":"2017","unstructured":"Wu X, Zhang Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet. 2017;18:517\u2013534","journal-title":"Nat Rev Genet"},{"key":"10351_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17:487\u2013500","journal-title":"Nat Rev Genet"},{"key":"10351_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tig.2017.11.005","volume":"34","author":"Q Sun","year":"2018","unstructured":"Sun Q, Hao Q, Prasanth KV. Nuclear long noncoding RNAs: key regulators of gene expression. Trends Genet. 2018;34:142\u2013157","journal-title":"Trends Genet"},{"key":"10351_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"AM Mohr","year":"2015","unstructured":"Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35:3\u201311","journal-title":"Semin Liver Dis"},{"key":"10351_CR18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/cancers13061265","volume":"13","author":"M Arechederra","year":"2021","unstructured":"Arechederra M, Recalde M, G\u00e1rate-Rasc\u00f3n M, Fern\u00e1ndez-Barrena MG, \u00c1vila MA, Berasain C. Epigenetic biomarkers for the diagnosis and treatment of liver disease. Cancers (Basel). 2021;13:1265","journal-title":"Cancers (Basel)"},{"key":"10351_CR19","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.3748\/wjg.v27.i23.3182","volume":"27","author":"P Singh","year":"2021","unstructured":"Singh P, Kairuz D, Arbuthnot P, Bloom K. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol. 2021;27:3182\u20133207","journal-title":"World J Gastroenterol"},{"key":"10351_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","volume":"42","author":"M Dandri","year":"2020","unstructured":"Dandri M. Epigenetic modulation in chronic hepatitis B virus infection. Semin Immunopathol. 2020;42:173\u2013185","journal-title":"Semin Immunopathol"},{"key":"10351_CR21","doi-asserted-by":"crossref","unstructured":"Sivasudhan E, Blake N, Lu Z, Meng J, Rong R (2022) Hepatitis B viral protein HBx and the molecular mechanisms modulating the hallmarks of hepatocellular carcinoma: a comprehensive review. Cells 11","DOI":"10.3390\/cells11040741"},{"key":"10351_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41598-020-57637-z","volume":"10","author":"CK Chong","year":"2020","unstructured":"Chong CK, Cheng CYS, Tsoi SYJ, Huang FY, Liu F, Fung J, et al. HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA. Sci Rep. 2020;10:802","journal-title":"Sci Rep"},{"key":"10351_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100167","volume":"2","author":"MG Fern\u00e1ndez-Barrena","year":"2020","unstructured":"Fern\u00e1ndez-Barrena MG, Arechederra M, Colyn L, Berasain C, Avila MA. Epigenetics in hepatocellular carcinoma development and therapy: the tip of the iceberg. JHEP Rep. 2020;2: 100167","journal-title":"JHEP Rep"},{"key":"10351_CR24","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3389\/fgene.2019.01150","volume":"10","author":"WJ Locke","year":"2019","unstructured":"Locke WJ, Guanzon D, Ma C, Liew YJ, Duesing KR, Fung KYC, et al. DNA methylation cancer biomarkers: translation to the clinic. Front Genet. 2019;10:1150","journal-title":"Front Genet"},{"key":"10351_CR25","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/onc.2016.340","volume":"36","author":"NA Wijetunga","year":"2017","unstructured":"Wijetunga NA, Pascual M, Tozour J, Delahaye F, Alani M, Adeyeye M, et al. A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets. Oncogene. 2017;36:2030\u20132044","journal-title":"Oncogene"},{"key":"10351_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/carcin\/bgx005","volume":"38","author":"J Kuramoto","year":"2017","unstructured":"Kuramoto J, Arai E, Tian Y, Funahashi N, Hiramoto M, Nammo T, et al. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis. Carcinogenesis. 2017;38:261\u2013270","journal-title":"Carcinogenesis"},{"key":"10351_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/mmr.2015.4545","volume":"13","author":"X Fu","year":"2016","unstructured":"Fu X, Song X, Li Y, Tan D, Liu G. Hepatitis B virus X protein upregulates DNA methyltransferase 3A\/3B and enhances SOCS-1CpG island methylation. Mol Med Rep. 2016;13:301\u2013308","journal-title":"Mol Med Rep"},{"key":"10351_CR28","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.3892\/or.2017.5518","volume":"37","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Hu Y, Shen X, Lao Y, Zhang L, Qiu X, et al. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma. Oncol Rep. 2017;37:2811\u20132818","journal-title":"Oncol Rep"},{"key":"10351_CR29","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1053\/j.gastro.2007.01.034","volume":"132","author":"IY Park","year":"2007","unstructured":"Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, et al. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology. 2007;132:1476\u20131494","journal-title":"Gastroenterology"},{"key":"10351_CR30","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1099\/jgv.0.000958","volume":"98","author":"JH Choi","year":"2017","unstructured":"Choi JH, Jeong H, Jang KL. Hepatitis B virus X protein suppresses all-trans retinoic acid-induced apoptosis in human hepatocytes by repressing p14 expression via DNA methylation. J Gen Virol. 2017;98:2786\u20132798","journal-title":"J Gen Virol"},{"key":"10351_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ijc.28697","volume":"135","author":"Q Xie","year":"2014","unstructured":"Xie Q, Chen L, Shan X, Shan X, Tang J, Zhou F, et al. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway. Int J Cancer. 2014;135:635\u2013646","journal-title":"Int J Cancer"},{"key":"10351_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41388-020-01498-3","volume":"40","author":"Y Yan","year":"2021","unstructured":"Yan Y, Huang P, Mao K, He C, Xu Q, Zhang M, et al. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression. Oncogene. 2021;40:28\u201345","journal-title":"Oncogene"},{"key":"10351_CR33","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1128\/JVI.02280-09","volume":"84","author":"P Vivekanandan","year":"2010","unstructured":"Vivekanandan P, Daniel HD, Kannangai R, Martinez-Murillo F, Torbenson M. Hepatitis B virus replication induces methylation of both host and viral DNA. J Virol. 2010;84:4321\u20134329","journal-title":"J Virol"},{"key":"10351_CR34","first-page":"941","volume":"21","author":"X Liu","year":"2009","unstructured":"Liu X, Xu Q, Chen W, Cao H, Zheng R, Li G. Hepatitis B virus DNA-induced carcinogenesis of human normal liver cells by virtue of nonmethylated CpG DNA. Oncol Rep. 2009;21:941\u2013947","journal-title":"Oncol Rep"},{"key":"10351_CR35","first-page":"1491","volume":"6","author":"L Koumbi","year":"2015","unstructured":"Koumbi L, Karayiannis P. The epigenetic control of hepatitis B virus modulates the outcome of infection. Front Microbiol. 2015;6:1491","journal-title":"Front Microbiol"},{"key":"10351_CR36","doi-asserted-by":"publisher","first-page":"14554","DOI":"10.1073\/pnas.0604469103","volume":"103","author":"M Shamay","year":"2006","unstructured":"Shamay M, Krithivas A, Zhang J, Hayward SD. Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi\u2019s sarcoma-associated herpesvirus LANA. Proc Natl Acad Sci USA. 2006;103:14554\u201314559","journal-title":"Proc Natl Acad Sci USA"},{"key":"10351_CR37","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1158\/0008-5472.CAN-08-3070","volume":"69","author":"R Hino","year":"2009","unstructured":"Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 2009;69:2766\u20132774","journal-title":"Cancer Res"},{"key":"10351_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.yexmp.2010.06.013","volume":"89","author":"YZ Zhu","year":"2010","unstructured":"Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q, et al. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis. Exp Mol Pathol. 2010;89:268\u2013275","journal-title":"Exp Mol Pathol"},{"key":"10351_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1099\/vir.0.015149-0","volume":"91","author":"JK Jung","year":"2010","unstructured":"Jung JK, Park SH, Jang KL. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation. J Gen Virol. 2010;91:493\u2013500","journal-title":"J Gen Virol"},{"key":"10351_CR40","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1099\/vir.0.029512-0","volume":"92","author":"SH Park","year":"2011","unstructured":"Park SH, Jung JK, Lim JS, Tiwari I, Jang KL. Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation. J Gen Virol. 2011;92:1309\u20131317","journal-title":"J Gen Virol"},{"key":"10351_CR41","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/onc.2011.255","volume":"31","author":"A Arzumanyan","year":"2012","unstructured":"Arzumanyan A, Friedman T, Kotei E, Ng IO, Lian Z, Feitelson MA. Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene. 2012;31:563\u2013572","journal-title":"Oncogene"},{"key":"10351_CR42","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.7150\/thno.48739","volume":"11","author":"G Song","year":"2021","unstructured":"Song G, Zhu X, Xuan Z, Zhao L, Dong H, Chen J, et al. Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma. Theranostics. 2021;11:2318\u20132333","journal-title":"Theranostics"},{"key":"10351_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.canlet.2012.01.038","volume":"342","author":"IP Pogribny","year":"2014","unstructured":"Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. 2014;342:223\u2013230","journal-title":"Cancer Lett"},{"key":"10351_CR44","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.3390\/ijms22052778","volume":"22","author":"M Markouli","year":"2021","unstructured":"Markouli M, Strepkos D, Basdra EK, Papavassiliou AG, Piperi C. Prominent role of histone modifications in the regulation of tumor metastasis. Int J Mol Sci. 2021;22:2278","journal-title":"Int J Mol Sci"},{"key":"10351_CR45","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.3390\/ijms21238894","volume":"21","author":"PK Rajan","year":"2020","unstructured":"Rajan PK, Udoh UA, Sanabria JD, Banerjee M, Smith G, Schade MS, et al. The role of histone acetylation-\/methylation-mediated apoptotic gene regulation in hepatocellular carcinoma. Int J Mol Sci. 2020;21:8894","journal-title":"Int J Mol Sci"},{"key":"10351_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-15-8104-5_1","volume":"1283","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Sun Z, Jia J, Du T, Zhang N, Tang Y, et al. Overview of histone modification. Adv Exp Med Biol. 2021;1283:1\u201316","journal-title":"Adv Exp Med Biol"},{"key":"10351_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.07.015","author":"ME Neganova","year":"2020","unstructured":"Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G. Histone modifications in epigenetic regulation of cancer: perspectives and achieved progress. Semin Cancer Biol. 2020. https:\/\/doi.org\/10.1016\/j.semcancer.2020.07.015","journal-title":"Semin Cancer Biol"},{"key":"10351_CR48","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/hep.30947","volume":"71","author":"W Gao","year":"2020","unstructured":"Gao W, Jia Z, Tian Y, Yang P, Sun H, Wang C, et al. HBx protein contributes to liver carcinogenesis by H3K4me3 modification through stabilizing WD repeat domain 5 protein. Hepatology. 2020;71:1678\u20131695","journal-title":"Hepatology"},{"key":"10351_CR49","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1038\/s41598-018-23318-1","volume":"8","author":"H Hamamoto","year":"2018","unstructured":"Hamamoto H, Maemura K, Matsuo K, Taniguchi K, Tanaka Y, Futaki S, et al. Delta-like 3 is silenced by HBx via histone acetylation in HBV-associated HCCs. Sci Rep. 2018;8:4842","journal-title":"Sci Rep"},{"key":"10351_CR50","first-page":"2209","volume":"39","author":"Y Mizuno","year":"2018","unstructured":"Mizuno Y, Maemura K, Tanaka Y, Hirata A, Futaki S, Hamamoto H, et al. Expression of delta-like 3 is downregulated by aberrant DNA methylation and histone modification in hepatocellular carcinoma. Oncol Rep. 2018;39:2209\u20132216","journal-title":"Oncol Rep"},{"key":"10351_CR51","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/infdis\/jiaa317","volume":"222","author":"Y Takeuchi","year":"2020","unstructured":"Takeuchi Y, Tsuge M, Tsushima K, Suehiro Y, Fujino H, Ono A, et al. Signal activation of hepatitis B Virus-related hepatocarcinogenesis by up-regulation of SUV39h1. J Infect Dis. 2020;222:2061\u20132070","journal-title":"J Infect Dis"},{"key":"10351_CR52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.yexmp.2015.08.020","volume":"99","author":"DY Wang","year":"2015","unstructured":"Wang DY, Zou LP, Liu XJ, Zhu HG, Zhu R. Hepatitis B virus X protein induces the histone H3 lysine 9 trimethylation on the promoter of p16 gene in hepatocarcinogenesis. Exp Mol Pathol. 2015;99:399\u2013408","journal-title":"Exp Mol Pathol"},{"key":"10351_CR53","first-page":"1019","volume":"55","author":"Y Ye","year":"2019","unstructured":"Ye Y, Yang J, Hu Q, Mao J, Yang Q, Chen H, et al. SIP1 serves a role in HBx-induced liver cancer growth and metastasis. Int J Oncol. 2019;55:1019\u20131032","journal-title":"Int J Oncol"},{"key":"10351_CR54","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3390\/cancers12092622","volume":"12","author":"TS Han","year":"2020","unstructured":"Han TS, Hur K, Cho HS, Ban HS. Epigenetic associations between lncRNA\/circRNA and miRNA in hepatocellular carcinoma. Cancers (Basel). 2020;12:2622","journal-title":"Cancers (Basel)"},{"key":"10351_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153369","volume":"219","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Honarmand Tamizkar K, Hussen BM, Taheri M. MicroRNA signature in liver cancer. Pathol Res Pract. 2021;219: 153369","journal-title":"Pathol Res Pract"},{"key":"10351_CR56","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.biopha.2018.12.131","volume":"111","author":"L Jun","year":"2019","unstructured":"Jun L, Yang G, Zhisu L. The utility of serum exosomal microRNAs in hepatocellular carcinoma. Biomed Pharmacother. 2019;111:1221\u20131227","journal-title":"Biomed Pharmacother"},{"key":"10351_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4331\/wjbc.v8.i1.45","volume":"8","author":"S Oliveto","year":"2017","unstructured":"Oliveto S, Mancino M, Manfrini N, Biffo S. Role of microRNAs in translation regulation and cancer. World J Biol Chem. 2017;8:45\u201356","journal-title":"World J Biol Chem"},{"key":"10351_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21037\/ncri.2018.04.06","volume":"2","author":"DV Silva Rodrigues","year":"2018","unstructured":"Silva Rodrigues DV, Silva Monteiro VV, Navegantes-Lima KC, de Brito Oliveira AL, de Fran\u00e7a Gaspar SL, Gon\u00e7alves Quadros LB, et al. MicroRNAs in cell cycle progression and proliferation: molecular mechanisms and pathways. Non-Coding RNA Investig. 2018;2:28","journal-title":"Non-Coding RNA Investig"},{"key":"10351_CR59","doi-asserted-by":"publisher","first-page":"14885","DOI":"10.1002\/jcb.28750","volume":"120","author":"QY Zhang","year":"2019","unstructured":"Zhang QY, Men CJ, Ding XW. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN. J Cell Biochem. 2019;120:14885\u201314898","journal-title":"J Cell Biochem"},{"key":"10351_CR60","first-page":"2221","volume":"17","author":"J Wang","year":"2019","unstructured":"Wang J, Chu Y, Xu M, Zhang X, Zhou Y, Xu M. miR-21 promotes cell migration and invasion of hepatocellular carcinoma by targeting KLF5. Oncol Lett. 2019;17:2221\u20132227","journal-title":"Oncol Lett"},{"key":"10351_CR61","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","volume":"50","author":"ED Tait Wojno","year":"2019","unstructured":"Tait Wojno ED, Hunter CA, Stumhofer JS. The Immunobiology of the interleukin-12 family: room for discovery. Immunity. 2019;50:851\u2013870","journal-title":"Immunity"},{"key":"10351_CR62","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.3892\/or.2016.5026","volume":"36","author":"D Yin","year":"2016","unstructured":"Yin D, Wang Y, Sai W, Zhang L, Miao Y, Cao L, et al. HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12. Oncol Rep. 2016;36:2305\u20132312","journal-title":"Oncol Rep"},{"key":"10351_CR63","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.3892\/mmr.2017.6363","volume":"15","author":"Z Hou","year":"2017","unstructured":"Hou Z, Quan J. Hepatitis B virus X protein increases microRNA-21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog\/phosphoinositide 3-kinase\/protein kinase B signaling pathway. Mol Med Rep. 2017;15:3285\u20133291","journal-title":"Mol Med Rep"},{"key":"10351_CR64","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbrc.2020.06.018","volume":"529","author":"M Ochi","year":"2020","unstructured":"Ochi M, Otsuka M, Maruyama R, Koike K. HBx increases EGFR expression by inhibiting miR129-5p function. Biochem Biophys Res Commun. 2020;529:198\u2013203","journal-title":"Biochem Biophys Res Commun"},{"key":"10351_CR65","doi-asserted-by":"publisher","first-page":"40089","DOI":"10.1038\/srep40089","volume":"7","author":"Y Tian","year":"2017","unstructured":"Tian Y, Xiao X, Gong X, Peng F, Xu Y, Jiang Y, et al. HBx promotes cell proliferation by disturbing the cross-talk between miR-181a and PTEN. Sci Rep. 2017;7:40089","journal-title":"Sci Rep"},{"key":"10351_CR66","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.7150\/thno.37717","volume":"9","author":"X Lin","year":"2019","unstructured":"Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, et al. HBX-induced miR-5188 impairs FOXO1 to stimulate \u03b2-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma. Theranostics. 2019;9:7583\u20137598","journal-title":"Theranostics"},{"key":"10351_CR67","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41388-019-1107-9","volume":"39","author":"KS Dong","year":"2020","unstructured":"Dong KS, Chen Y, Yang G, Liao ZB, Zhang HW, Liang HF, et al. TGF-\u03b21 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p. Oncogene. 2020;39:1807\u20131820","journal-title":"Oncogene"},{"key":"10351_CR68","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/cdd.2017.87","volume":"24","author":"SJ Zhou","year":"2017","unstructured":"Zhou SJ, Deng YL, Liang HF, Jaoude JC, Liu FY. Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma. Cell Death Differ. 2017;24:1577\u20131587","journal-title":"Cell Death Differ"},{"key":"10351_CR69","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41467-020-14324-x","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang Y, Luo M, Zhang K, Zhang J, Gao T, Connell DO, et al. Nedd4 ubiquitylates VDAC2\/3 to suppress erastin-induced ferroptosis in melanoma. Nat Commun. 2020;11:433","journal-title":"Nat Commun"},{"key":"10351_CR70","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.7150\/ijbs.69454","volume":"18","author":"G Huang","year":"2022","unstructured":"Huang G, Xiang Z, Wu H, He Q, Dou R, Lin Z, et al. The lncRNA BDNF-AS\/WDR5\/FBXW7 axis mediates ferroptosis in gastric cancer peritoneal metastasis by regulating VDAC3 ubiquitination. Int J Biol Sci. 2022;18:1415\u20131433","journal-title":"Int J Biol Sci"},{"key":"10351_CR71","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13046-018-0681-y","volume":"37","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Song G, Yao L, Liu Y, Liu M, Li S, et al. miR-3928v is induced by HBx via NF-\u03baB\/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. J Exp Clin Cancer Res. 2018;37:14","journal-title":"J Exp Clin Cancer Res"},{"key":"10351_CR72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12967-016-0949-y","volume":"14","author":"XX Kong","year":"2016","unstructured":"Kong XX, Lv YR, Shao LP, Nong XY, Zhang GL, Zhang Y, et al. HBx-induced MiR-1269b in NF-\u03baB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells. J Transl Med. 2016;14:189","journal-title":"J Transl Med"},{"key":"10351_CR73","doi-asserted-by":"publisher","first-page":"56309","DOI":"10.18632\/oncotarget.10462","volume":"7","author":"WS Chen","year":"2016","unstructured":"Chen WS, Liu LC, Yen CJ, Chen YJ, Chen JY, Ho CY, et al. Nuclear IKK\u03b1 mediates microRNA-7\/-103\/107\/21 inductions to downregulate maspin expression in response to HBx overexpression. Oncotarget. 2016;7:56309\u201356323","journal-title":"Oncotarget"},{"key":"10351_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022888","volume":"6","author":"WK Yip","year":"2011","unstructured":"Yip WK, Cheng AS, Zhu R, Lung RW, Tsang DP, Lau SS, et al. Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development. PLoS ONE. 2011;6: e22888","journal-title":"PLoS ONE"},{"key":"10351_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.46","volume":"6","author":"FY Liu","year":"2015","unstructured":"Liu FY, Zhou SJ, Deng YL, Zhang ZY, Zhang EL, Wu ZB, et al. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway. Cell Death Dis. 2015;6: e1670","journal-title":"Cell Death Dis"},{"key":"10351_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152981","volume":"216","author":"Y Gao","year":"2020","unstructured":"Gao Y, Gu J, Wang Y, Fu D, Zhang W, Zheng G, et al. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Pathol Res Pract. 2020;216: 152981","journal-title":"Pathol Res Pract"},{"key":"10351_CR77","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.prp.2017.10.020","volume":"213","author":"T Shi","year":"2017","unstructured":"Shi T, Hua Q, Ma Z, Lv Q. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma. Pathol Res Pract. 2017;213:1464\u20131469","journal-title":"Pathol Res Pract"},{"key":"10351_CR78","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.12659\/MSM.895943","volume":"22","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Y, Wang P, Wang H, Su H, Zhou X, et al. HBX protein-induced downregulation of microRNA-18a is responsible for upregulation of connective tissue growth factor in HBV infection-associated hepatocarcinoma. Med Sci Monit. 2016;22:2492\u20132500","journal-title":"Med Sci Monit"},{"key":"10351_CR79","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/jcb.29471","volume":"121","author":"C Zhang","year":"2020","unstructured":"Zhang C, Liu P, Zhang C. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329. J Cell Biochem. 2020;121:2489\u20132499","journal-title":"J Cell Biochem"},{"key":"10351_CR80","doi-asserted-by":"publisher","first-page":"276","DOI":"10.20892\/j.issn.2095-3941.2018.0283","volume":"16","author":"Z Yang","year":"2019","unstructured":"Yang Z, Li J, Feng G, Wang Y, Yang G, Liu Y, et al. Hepatitis B virus X protein enhances hepatocarcinogenesis by depressing the targeting of NUSAP1 mRNA by miR-18b. Cancer Biol Med. 2019;16:276\u2013287","journal-title":"Cancer Biol Med"},{"key":"10351_CR81","first-page":"479","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ren H, Li J, Xue R, Liu H, Zhu Z, et al. Elevated HMGB1 expression induced by hepatitis B virus X protein promotes epithelial-mesenchymal transition and angiogenesis through STAT3\/miR-34a\/NF-\u03baB in primary liver cancer. Am J Cancer Res. 2021;11:479\u2013494","journal-title":"Am J Cancer Res"},{"key":"10351_CR82","doi-asserted-by":"publisher","first-page":"60962","DOI":"10.18632\/oncotarget.17631","volume":"8","author":"R Dai","year":"2017","unstructured":"Dai R, Peng F, Xiao X, Gong X, Jiang Y, Zhang M, et al. Hepatitis B virus X protein-induced upregulation of CAT-1 stimulates proliferation and inhibits apoptosis in hepatocellular carcinoma cells. Oncotarget. 2017;8:60962\u201360974","journal-title":"Oncotarget"},{"key":"10351_CR83","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13027-016-0085-6","volume":"11","author":"M Bandopadhyay","year":"2016","unstructured":"Bandopadhyay M, Sarkar N, Datta S, Das D, Pal A, Panigrahi R, et al. Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1\u2013p53 axis. Infect Agent Cancer. 2016;11:40","journal-title":"Infect Agent Cancer"},{"key":"10351_CR84","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/hepr.12618","volume":"46","author":"XM Hu","year":"2016","unstructured":"Hu XM, Yan XH, Hu YW, Huang JL, Cao SW, Ren TY, et al. miRNA-548p suppresses hepatitis B virus X protein associated hepatocellular carcinoma by downregulating oncoprotein hepatitis B x-interacting protein. Hepatol Res. 2016;46:804\u2013815","journal-title":"Hepatol Res"},{"key":"10351_CR85","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904\u2013914","journal-title":"Mol Cell"},{"key":"10351_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105195","volume":"160","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhang Y, Qin X, Geng H, Zuo D, Zhao Q. PI3K\/AKT\/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacol Res. 2020;160: 105195","journal-title":"Pharmacol Res"},{"key":"10351_CR87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nsmb.2942","volume":"22","author":"JS Mattick","year":"2015","unstructured":"Mattick JS, Rinn JL. Discovery and annotation of long noncoding RNAs. Nat Struct Mol Biol. 2015;22:5\u20137","journal-title":"Nat Struct Mol Biol"},{"key":"10351_CR88","doi-asserted-by":"publisher","first-page":"664","DOI":"10.7150\/ijbs.8232","volume":"10","author":"WH Xu","year":"2014","unstructured":"Xu WH, Zhang JB, Dang Z, Li X, Zhou T, Liu J, et al. Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK\/MAPK signaling pathway in hepatocellular carcinoma. Int J Biol Sci. 2014;10:664\u2013676","journal-title":"Int J Biol Sci"},{"key":"10351_CR89","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.gastro.2014.10.012","volume":"148","author":"C Cao","year":"2015","unstructured":"Cao C, Sun J, Zhang D, Guo X, Xie L, Li X, et al. The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of \u03b2-catenin in HCC cells. Gastroenterology. 2015;148:415\u201326.e18","journal-title":"Gastroenterology"},{"key":"10351_CR90","doi-asserted-by":"publisher","first-page":"220","DOI":"10.7150\/ijbs.50730","volume":"17","author":"D Yuan","year":"2021","unstructured":"Yuan D, Chen Y, Li X, Li J, Zhao Y, Shen J, et al. Long Non-coding RNAs: potential biomarkers and targets for hepatocellular carcinoma therapy and diagnosis. Int J Biol Sci. 2021;17:220\u2013235","journal-title":"Int J Biol Sci"},{"key":"10351_CR91","first-page":"18","volume":"56","author":"H Zhang","year":"2020","unstructured":"Zhang H, Chen X, Zhang J, Wang X, Chen H, Liu L, et al. Long non-coding RNAs in HBV-related hepatocellular carcinoma (review). Int J Oncol. 2020;56:18\u201332","journal-title":"Int J Oncol"},{"key":"10351_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.177","volume":"49","author":"B Zhang","year":"2017","unstructured":"Zhang B, Han S, Feng B, Chu X, Chen L, Wang R. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma. Exp Mol Med. 2017;49: e293","journal-title":"Exp Mol Med"},{"key":"10351_CR93","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12985-017-0903-5","volume":"14","author":"Y Jin","year":"2017","unstructured":"Jin Y, Wu D, Yang W, Weng M, Li Y, Wang X, et al. Hepatitis B virus x protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA. Virol J. 2017;14:238","journal-title":"Virol J"},{"key":"10351_CR94","doi-asserted-by":"publisher","first-page":"23521","DOI":"10.1038\/srep23521","volume":"6","author":"JJ Hu","year":"2016","unstructured":"Hu JJ, Song W, Zhang SD, Shen XH, Qiu XM, Wu HZ, et al. HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1\/CDK2 signaling. Sci Rep. 2016;6:23521","journal-title":"Sci Rep"},{"key":"10351_CR95","doi-asserted-by":"publisher","first-page":"26302","DOI":"10.1074\/jbc.M112.342113","volume":"287","author":"Y Du","year":"2012","unstructured":"Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 2012;287:26302\u201326311","journal-title":"J Biol Chem"},{"key":"10351_CR96","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.1243462","volume":"343","author":"J Lucifora","year":"2014","unstructured":"Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science. 2014;343:1221\u20131228","journal-title":"Science"},{"key":"10351_CR97","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2019.04.008","volume":"454","author":"Y Liu","year":"2019","unstructured":"Liu Y, Feng J, Sun M, Yang G, Yuan H, Wang Y, et al. Long non-coding RNA HULC activates HBV by modulating HBx\/STAT3\/miR-539\/APOBEC3B signaling in HBV-related hepatocellular carcinoma. Cancer Lett. 2019;454:158\u2013170","journal-title":"Cancer Lett"},{"key":"10351_CR98","first-page":"337","volume":"56","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li J, Wang S, Yang F, Zhou Y, Liu Y, et al. HBx-associated long non-coding RNA activated by TGF-\u03b2 promotes cell invasion and migration by inducing autophagy in primary liver cancer. Int J Oncol. 2020;56:337\u2013347","journal-title":"Int J Oncol"},{"key":"10351_CR99","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbrc.2018.11.091","volume":"508","author":"Z Hu","year":"2019","unstructured":"Hu Z, Huang P, Yan Y, Zhou Z, Wang J, Wu G. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion. Biochem Biophys Res Commun. 2019;508:79\u201386","journal-title":"Biochem Biophys Res Commun"},{"key":"10351_CR100","volume":"35","author":"F Zhang","year":"2021","unstructured":"Zhang F, Li Y, Gan L, Tong X, Qi D, Wang Q, et al. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA. FASEB J. 2021;35: e21529","journal-title":"FASEB J"},{"key":"10351_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108877","volume":"115","author":"T Chen","year":"2019","unstructured":"Chen T, Pei J, Wang J, Luo R, Liu L, Wang L, et al. HBx-related long non-coding RNA 01152 promotes cell proliferation and survival by IL-23 in hepatocellular carcinoma. Biomed Pharmacother. 2019;115: 108877","journal-title":"Biomed Pharmacother"},{"key":"10351_CR102","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/jb\/mvy120","volume":"165","author":"W Tu","year":"2019","unstructured":"Tu W, Yang Y, Song Y, Zhu W. Hepatitis B virus x protein accelerated the proliferation of hepatocellular carcinoma cell through lncRNA SNHG20\/PTEN pathway. J Biochem. 2019;165:423\u2013431","journal-title":"J Biochem"},{"key":"10351_CR103","doi-asserted-by":"publisher","first-page":"33791","DOI":"10.18632\/oncotarget.5667","volume":"6","author":"JL Huang","year":"2015","unstructured":"Huang JL, Ren TY, Cao SW, Zheng SH, Hu XM, Hu YW, et al. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma. Oncotarget. 2015;6:33791\u201333804","journal-title":"Oncotarget"},{"key":"10351_CR104","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.ymthe.2021.04.011","volume":"29","author":"W Song","year":"2021","unstructured":"Song W, Zheng C, Liu M, Xu Y, Qian Y, Zhang Z, et al. TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p. Mol Ther. 2021;29:2601\u20132616","journal-title":"Mol Ther"},{"key":"10351_CR105","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1002\/jcb.26823","volume":"120","author":"B He","year":"2019","unstructured":"He B, Peng F, Li W, Jiang Y. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K\/Akt signaling. J Cell Biochem. 2019;120:2908\u20132918","journal-title":"J Cell Biochem"},{"key":"10351_CR106","first-page":"845","volume":"7","author":"Z Hou","year":"2017","unstructured":"Hou Z, Xu X, Fu X, Tao S, Zhou J, Liu S, et al. HBx-related long non-coding RNA MALAT1 promotes cell metastasis via up-regulating LTBP3 in hepatocellular carcinoma. Am J Cancer Res. 2017;7:845\u2013856","journal-title":"Am J Cancer Res"},{"key":"10351_CR107","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.omtn.2019.04.021","volume":"16","author":"Z Chen","year":"2019","unstructured":"Chen Z, Yu W, Zhou Q, Zhang J, Jiang H, Hao D, et al. A novel lncRNA IHS promotes tumor proliferation and metastasis in HCC by regulating the ERK- and AKT\/GSK-3\u03b2-signaling pathways. Mol Ther Nucleic Acids. 2019;16:707\u2013720","journal-title":"Mol Ther Nucleic Acids"},{"key":"10351_CR108","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1111\/jcmm.14881","volume":"24","author":"Y Deng","year":"2020","unstructured":"Deng Y, Wei Z, Huang M, Xu G, Wei W, Peng B, et al. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p. J Cell Mol Med. 2020;24:1848\u20131865","journal-title":"J Cell Mol Med"},{"key":"10351_CR109","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1038\/s41388-020-1254-z","volume":"39","author":"P Huang","year":"2020","unstructured":"Huang P, Xu Q, Yan Y, Lu Y, Hu Z, Ou B, et al. HBx\/ER\u03b1 complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis. Oncogene. 2020;39:3774\u20133789","journal-title":"Oncogene"},{"key":"10351_CR110","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","volume":"63","author":"L Rivi\u00e8re","year":"2015","unstructured":"Rivi\u00e8re L, Gerossier L, Ducroux A, Dion S, Deng Q, Michel ML, et al. HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase. J Hepatol. 2015;63:1093\u20131102","journal-title":"J Hepatol"},{"key":"10351_CR111","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1099\/vir.0.019224-0","volume":"91","author":"M Tsuge","year":"2010","unstructured":"Tsuge M, Hiraga N, Akiyama R, Tanaka S, Matsushita M, Mitsui F, et al. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. J Gen Virol. 2010;91:1854\u20131864","journal-title":"J Gen Virol"},{"key":"10351_CR112","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","volume":"106","author":"L Belloni","year":"2009","unstructured":"Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci USA. 2009;106:19975\u201319979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10351_CR113","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1136\/gutjnl-2019-319637","volume":"69","author":"D Salerno","year":"2020","unstructured":"Salerno D, Chiodo L, Alfano V, Floriot O, Cottone G, Paturel A, et al. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription. Gut. 2020;69:2016\u20132024","journal-title":"Gut"},{"key":"10351_CR114","first-page":"67","volume":"42","author":"H Lee","year":"2019","unstructured":"Lee H, Jeong H, Lee SY, Kim SS, Jang KL. Hepatitis B virus X protein stimulates virus replication Via DNA methylation of the C-1619 in covalently closed circular DNA. Mol Cells. 2019;42:67\u201378","journal-title":"Mol Cells"},{"key":"10351_CR115","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jhep.2020.09.019","volume":"74","author":"ST Cheng","year":"2021","unstructured":"Cheng ST, Hu JL, Ren JH, Yu HB, Zhong S, Wai Wong VK, et al. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx. J Hepatol. 2021;74:522\u2013534","journal-title":"J Hepatol"},{"key":"10351_CR116","doi-asserted-by":"crossref","unstructured":"Andrisani O (2021) Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma. Hepatoma Res 7","DOI":"10.20517\/2394-5079.2020.83"},{"key":"10351_CR117","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cbpa.2020.04.008","volume":"57","author":"FP Coss\u00edo","year":"2020","unstructured":"Coss\u00edo FP, Esteller M, Berdasco M. Towards a more precise therapy in cancer: exploring epigenetic complexity. Curr Opin Chem Biol. 2020;57:41\u201349","journal-title":"Curr Opin Chem Biol"},{"key":"10351_CR118","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13148-015-0157-2","volume":"7","author":"C Nervi","year":"2015","unstructured":"Nervi C, De Marinis E, Codacci-Pisanelli G. Epigenetic treatment of solid tumours: a review of clinical trials. Clin Epigenet. 2015;7:127","journal-title":"Clin Epigenet"},{"key":"10351_CR119","first-page":"276","volume":"28","author":"R Srisuttee","year":"2012","unstructured":"Srisuttee R, Koh SS, Kim SJ, Malilas W, Boonying W, Cho IR, et al. Hepatitis B virus X (HBX) protein upregulates \u03b2-catenin in a human hepatic cell line by sequestering SIRT1 deacetylase. Oncol Rep. 2012;28:276\u2013282","journal-title":"Oncol Rep"},{"key":"10351_CR120","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbrc.2012.10.102","volume":"429","author":"R Srisuttee","year":"2012","unstructured":"Srisuttee R, Koh SS, Malilas W, Moon J, Cho IR, Jhun BH, et al. SIRT1 sensitizes hepatocellular carcinoma cells expressing hepatitis B virus X protein to oxidative stress-induced apoptosis. Biochem Biophys Res Commun. 2012;429:45\u201350","journal-title":"Biochem Biophys Res Commun"},{"key":"10351_CR121","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1158\/1940-6207.CAPR-12-0001","volume":"5","author":"HC Lin","year":"2012","unstructured":"Lin HC, Chen YF, Hsu WH, Yang CW, Kao CH, Tsai TF. Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prev Res (Phila). 2012;5:952\u2013962","journal-title":"Cancer Prev Res (Phila)"},{"key":"10351_CR122","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4142\/jvs.2017.18.4.419","volume":"18","author":"S Park","year":"2017","unstructured":"Park S, Lim J, Kim JR, Cho S. Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma. J Vet Sci. 2017;18:419\u2013429","journal-title":"J Vet Sci"},{"key":"10351_CR123","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1002\/jcb.26555","volume":"119","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, Liu H. Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX. J Cell Biochem. 2018;119:4482\u20134495","journal-title":"J Cell Biochem"},{"key":"10351_CR124","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.bbrc.2013.07.094","volume":"438","author":"H Lee","year":"2013","unstructured":"Lee H, Sohn JB, Kim SS, Jang KL. DNA methyltransferase inhibitor assay system based on the HBx-induced DNA methylation of E-cadherin. Biochem Biophys Res Commun. 2013;438:540\u2013545","journal-title":"Biochem Biophys Res Commun"},{"key":"10351_CR125","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-019-0267-4","volume":"17","author":"D Morel","year":"2020","unstructured":"Morel D, Jeffery D, Aspeslagh S, Almouzni G, Postel-Vinay S. Combining epigenetic drugs with other therapies for solid tumours\u2014past lessons and future promise. Nat Rev Clin Oncol. 2020;17:91\u2013107","journal-title":"Nat Rev Clin Oncol"},{"key":"10351_CR126","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1349-7006.1989.tb02308.x","volume":"80","author":"K Araki","year":"1989","unstructured":"Araki K, Miyazaki J, Tsurimoto T, Inomoto T, Iwanaga T, Matsubara K, et al. Demethylation by 5-azacytidine results in the expression of hepatitis B virus surface antigen in transgenic mice. Jpn J Cancer Res. 1989;80:295\u2013298","journal-title":"Jpn J Cancer Res"},{"key":"10351_CR127","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ijc.2910520124","volume":"52","author":"E Miyoshi","year":"1992","unstructured":"Miyoshi E, Fujii J, Hayashi N, Ueda K, Towata T, Fusamoto H, et al. Enhancement of hepatitis-B surface-antigen expression by 5-azacytidine in a hepatitis-B-virus-transfected cell line. Int J Cancer. 1992;52:137\u2013140","journal-title":"Int J Cancer"},{"key":"10351_CR128","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/hep.29479","volume":"66","author":"X Hong","year":"2017","unstructured":"Hong X, Kim ES, Guo H. Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B. Hepatology. 2017;66:2066\u20132077","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10351-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10351-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10351-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T15:33:56Z","timestamp":1668353636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10351-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10351"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10351-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors Liqiong Yang, Tao Zou, Yao Chen, Yueshui Zhao, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Zhangang Xiao and Jing Shen declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}